TPR and neoplasm: Thus, while we show here that TPr can block the interaction of platelets and circulating tumor cells, it is likely that the antimetastatic efficacy of TPr inhibition is multifaceted and results from multiple mechanisms including the inhibition of platelet-tumor cell interactions and changes to endothelial barrier function.